Rockefeller scientists engineer next-generation antibody to replace IVIG therapy
Intravenous immunoglobulin (IVIG) therapy involves infusing patients with naturally occurring IgG antibodies to treat autoimmune conditions. With origins…
Northwestern team develops antibody to expose hidden pancreatic cancer cells
Pancreatic cancer is notoriously hard to treat and often resists the most advanced immunotherapies. Northwestern Medicine scientists have…
Integrating physicochemical laws into future AI models for better drug design
Proteins play a key role not only in the body, but also in medicine: they either serve as…
Antibody discovery could provide new treatment options for aggressive breast cancers
A new potential antibody therapy strategy which restricts the growth of treatment-resistant breast cancers has been developed by scientists.…
New wearable sensor tracks vitamin B6 levels in sweat
Vitamin B6, which is absorbed from a broad range of foods, helps bolster immune system function and neurotransmitters…
New insights into malaria proteins offer pathway to blocking parasite transmission
Using millions of microscope images magnified up to 130,000 times, researchers from Radboud university medical center and Toronto…
Bispecific Antibodies Market – Global Forecast 2025-2032,
Dublin, Oct. 09, 2025 (GLOBE NEWSWIRE) — The “Bispecific Antibodies Market – Global Forecast 2025-2032” report has been…
Vaccinated but Still Got COVID? A New Study Helps Explains Why
Researchers uncovered four unique immune response patterns to COVID-19 vaccines, including a “rapid-decliner” group that lost protection faster…
New study reveals silent onset of rheumatoid arthritis
Scientists have discovered that rheumatoid arthritis (RA) doesn’t start when the pain begins. It silently starts years earlier.…
Blood and brain biomarkers transform how doctors confirm Alzheimer’s disease
By integrating clinical assessment with cutting-edge biomarkers, researchers chart a practical pathway to faster and fairer Alzheimer’s diagnosis,…
NIH awards $3.4 million to support research on Crimean-Congo hemorrhagic fever virus
Crimean-Congo hemorrhagic fever virus, or CCHFV, is a biosafety level 4 pathogen and a Category A bioterrorism agent,…
New microfluidic-based biosensing platform helps track live antibody secretion dynamics
A research team at the Terasaki Institute, led by Dr. Vadim Jucaud in collaboration with Dr. Jing Yong…